These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37972723)

  • 1. Neutrophils as potential therapeutic targets for breast cancer.
    Gong YT; Zhang LJ; Liu YC; Tang M; Lin JY; Chen XY; Chen YX; Yan Y; Zhang WD; Jin JM; Luan X
    Pharmacol Res; 2023 Dec; 198():106996. PubMed ID: 37972723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Rosetta Stone for Breast Cancer: Prognostic Value and Dynamic Regulation of Neutrophil in Tumor Microenvironment.
    Zhang W; Shen Y; Huang H; Pan S; Jiang J; Chen W; Zhang T; Zhang C; Ni C
    Front Immunol; 2020; 11():1779. PubMed ID: 32849640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated neutrophils and neutrophil-targeted cancer therapies.
    Que H; Fu Q; Lan T; Tian X; Wei X
    Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188762. PubMed ID: 35853517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.
    Mehraj U; Ganai RA; Macha MA; Hamid A; Zargar MA; Bhat AA; Nasser MW; Haris M; Batra SK; Alshehri B; Al-Baradie RS; Mir MA; Wani NA
    Cell Oncol (Dordr); 2021 Dec; 44(6):1209-1229. PubMed ID: 34528143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model.
    Nascimento C; Ferreira F
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188587. PubMed ID: 34237352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring neutrophil functionality in breast cancer progression: A review.
    Obeagu EI; Obeagu GU
    Medicine (Baltimore); 2024 Mar; 103(13):e37654. PubMed ID: 38552040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting and exploitation of tumor-associated neutrophils to enhance immunotherapy and drug delivery for cancer treatment.
    Zhang Y; Guoqiang L; Sun M; Lu X
    Cancer Biol Med; 2020 Feb; 17(1):32-43. PubMed ID: 32296575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the Neutrophil in the Pathogenesis of Advanced Cancer and Impaired Responsiveness to Therapy.
    Rapoport BL; Steel HC; Theron AJ; Smit T; Anderson R
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32244751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil Heterogeneity in Cancer: From Biology to Therapies.
    Lecot P; Sarabi M; Pereira Abrantes M; Mussard J; Koenderman L; Caux C; Bendriss-Vermare N; Michallet MC
    Front Immunol; 2019; 10():2155. PubMed ID: 31616408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Mediated Neutrophil Polarization and Therapeutic Implications.
    Raftopoulou S; Valadez-Cosmes P; Mihalic ZN; Schicho R; Kargl J
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-activated neutrophils promote metastasis in breast cancer via the G-CSF-RLN2-MMP-9 axis.
    Sheng Y; Peng W; Huang Y; Cheng L; Meng Y; Kwantwi LB; Yang J; Xu J; Xiao H; Kzhyshkowska J; Wu Q
    J Leukoc Biol; 2023 Mar; 113(4):383-399. PubMed ID: 36801950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Infiltrates in Breast Cancer: Recent Updates and Clinical Implications.
    Dieci MV; Miglietta F; Guarneri V
    Cells; 2021 Jan; 10(2):. PubMed ID: 33498711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unveiling the Immune Microenvironment's Role in Breast Cancer: A Glimpse into Promising Frontiers.
    Kotsifaki A; Alevizopoulos N; Dimopoulou V; Armakolas A
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinoma.
    Chung JY; Tang PC; Chan MK; Xue VW; Huang XR; Ng CS; Zhang D; Leung KT; Wong CK; Lee TL; Lam EW; Nikolic-Paterson DJ; To KF; Lan HY; Tang PM
    Nat Commun; 2023 Mar; 14(1):1794. PubMed ID: 37002229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophils, a candidate biomarker and target for radiation therapy?
    Schernberg A; Blanchard P; Chargari C; Deutsch E
    Acta Oncol; 2017 Nov; 56(11):1522-1530. PubMed ID: 28835188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethnic disparities in the immune microenvironment of triple negative breast cancer and its role in therapeutic outcomes.
    Zajac KK; Malla S; Babu RJ; Raman D; Tiwari AK
    Cancer Rep (Hoboken); 2023 Sep; 6 Suppl 1(Suppl 1):e1779. PubMed ID: 36632988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated neutrophils as new players in immunosuppressive process of the tumor microenvironment in breast cancer.
    Hajizadeh F; Aghebati Maleki L; Alexander M; Mikhailova MV; Masjedi A; Ahmadpour M; Hashemi V; Jadidi-Niaragh F
    Life Sci; 2021 Jan; 264():118699. PubMed ID: 33137368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Always Look On the Bright Side: Anti-Tumor Functions of Neutrophils.
    Vols S; Sionov RV; Granot Z
    Curr Pharm Des; 2017; 23(32):4862-4892. PubMed ID: 28677504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer immune microenvironment: from pre-clinical models to clinical therapies.
    Wilson BE; Gorrini C; Cescon DW
    Breast Cancer Res Treat; 2022 Jan; 191(2):257-267. PubMed ID: 34731350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum amyloid A 1 induces suppressive neutrophils through the Toll-like receptor 2-mediated signaling pathway to promote progression of breast cancer.
    Niu X; Yin L; Yang X; Yang Y; Gu Y; Sun Y; Yang M; Wang Y; Zhang Q; Ji H
    Cancer Sci; 2022 Apr; 113(4):1140-1153. PubMed ID: 35102665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.